• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » AcuFocus adds $21M for Kamra presbyopia inlay

AcuFocus adds $21M for Kamra presbyopia inlay

September 3, 2014 By Brad Perriello

AcuFocus adds $21M for Kamra presbyopia inlay

AcuFocus said today that it raised another $21 million in an oversubscribed round as it awaits a decision from the FDA on its Kamra device, a corneal inlay designed to treat near vision loss, or presbyopia.

Irvine, Calif.-based AcuFocus said all of its previous backers participated in the round, including HealthCare Royalty Partners, SV Life Sciences, Versant Ventures, Carlyle Group, Accuitive Medical Ventures and Medtronic (NYSE:MDT).

The Kamra device won CE Mark approval in the European Union in 2005. AcuFocus, which raised a $65 million round in 2011, said it plans to use the new funds to extend its reach in Europe and lay the groundwork for commercialization in the U.S. as it works with the FDA on its bid for pre-market approval.

An FDA advisory panel in June issued a mixed verdict on the Kamra inlay, voting that the device is effective but splitting over its safety. The Ophthalmic Devices panel voted 7-1 that Kamra is effective but required chairman Dr. Neil Bressler to break a tie to make the vote 5-4 against on the safety question. The panel was also divided over the Kamra Inlay’s benefits versus its risks, voting 4-3 with 1 abstention that the benefits top the risks.

"We are pleased to have the continued support of all our investment partners as we prepare our business for the next phase of growth," chairman & CEO Jim Mazzo said in prepared remarks. "While we work closely with the FDA on advancing our PMA submission for the Kamra inlay, we are taking steps to expand our sales and marketing organization. We are also focusing significant R&D resources on development of a new presbyopia-correcting intraocular lens that we plan to introduce soon."

"We are confident in the strength and performance of the AcuFocus technology, strategy and management team to deliver proven and reliable solutions for presbyopes who want a fuller range of vision without glasses," added SV Life Sciences chairman emeritus James Garvey.

Filed Under: Funding Roundup, News Well, Optical/Ophthalmic Tagged With: AcuFocus Inc., Venture Capital/Private Equity

More recent news

  • Medtronic partners with IRCAD on Hugo, Affera surgical training
  • 23andMe co-founder wins bid to take back control of company
  • Neurent Medical opens new manufacturing facility in Ireland
  • Brain Navi wins FDA nod for neurosurgical robot
  • Adona Medical completes enrollment in first-in-human interatrial shunt trial

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy